Values First Advisors, Inc. Essa Pharma Inc. Transaction History

Values First Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 20, 2022	BUY	$3.15 - $7.94 $7,941 - $20,016	2,521 Added 20.86%	14,605 $46,000
Q1 2022 May 03, 2022	SELL	$6.18 - $14.44 $9,789 - $22,872	-1,584 Reduced 11.59%	12,084 $75,000
Q4 2021 Mar 10, 2022	BUY	$7.8 - $14.38 $106,610 - $196,545	13,668 New	13,668 $194,000
Q3 2021 Nov 15, 2022	SELL	$7.76 - $29.37 $29,713 - $112,457	-3,829 Reduced 26.22%	10,776 $86,000

35.1M

15.8K

21K

Ticker EPIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,073,100
Market Cap $72.3M
Description
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...

Get notified when there are updates to the investment portfolio of Values First Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Values First Advisors, Inc. with notifications on news.